Trials / Completed
CompletedNCT04075032
Pomegranate Consumption by Poly-medicated Metabolic Syndrome Patients
Effect of a Pomegranate Extract on Metabolic and Inflammatory Markers, and the Gut Microbiota of Poly-medicated Metabolic Syndrome Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- National Research Council, Spain · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to evaluate whether the medication in polymedicated metabolic syndrome patients could determine the effects of a pomegranate extract on i) metabolic markers, ii) inflammatory markers, and iii) the modulation of the gut microbiota.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pomegranate extract | Pomegranate extract consumption (900 mg/day) for 4 weeks |
| OTHER | Placebo | Placebo (microcrystalline cellulose) consumption (900 mg/day) for 4 weeks |
Timeline
- Start date
- 2018-06-10
- Primary completion
- 2019-07-21
- Completion
- 2019-12-31
- First posted
- 2019-08-30
- Last updated
- 2020-09-10
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04075032. Inclusion in this directory is not an endorsement.